CTRE:NGS-CareTrust REIT Inc. (USD)

EQUITY | REIT - Healthcare Facilities | Nasdaq Global Select

Last Closing

USD 30.86

Change

+0.10 (+0.33)%

Market Cap

USD 0.83B

Volume

1.89M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT Inc is engaged in the ownership, acquisition and leasing of healthcare-related properties. The Company also owns and operates independent living facilities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.83 (+0.65%)

USD 77.48B
VTR Ventas Inc

+0.29 (+0.45%)

USD 26.47B
DOC Healthpeak Properties Inc

+0.27 (+1.19%)

USD 15.80B
AHR American Healthcare REIT, Inc.

-0.02 (-0.08%)

USD 3.99B
NHI National Health Investors Inc

+1.07 (+1.29%)

USD 3.65B
CWSRF Chartwell Retirement Residence..

-0.04 (-0.35%)

USD 3.10B
LTC LTC Properties Inc

+0.07 (+0.19%)

USD 1.60B
SILA Sila Realty Trust, Inc.

-0.14 (-0.55%)

USD 1.38B
UHT Universal Health Realty Income..

+0.20 (+0.44%)

USD 0.63B
CHCT Community Healthcare Trust Inc

+0.31 (+1.74%)

USD 0.47B

ETFs Containing CTRE

FXU First Trust Utilities Alp.. 4.41 % 0.63 %

+0.17 (+0.22%)

N/A
HDLV 3.31 % 0.00 %

N/A

N/A
XLUY 3.00 % 0.00 %

N/A

N/A
CZA Invesco Zacks Mid-Cap ETF 1.84 % 0.65 %

+0.17 (+0.22%)

N/A
HSMV First Trust Horizon Manag.. 1.59 % 0.00 %

+0.08 (+0.22%)

USD 0.02B
PSCF Invesco S&P SmallCap Fina.. 1.34 % 0.29 %

+0.37 (+0.22%)

USD 0.02B
XSLV Invesco S&P SmallCap Low .. 1.14 % 0.25 %

+0.19 (+0.22%)

USD 0.33B
DIVA 1.07 % 1.00 %

N/A

N/A
ULOV:LSE 0.72 % 0.00 %

N/A

N/A
USVM VictoryShares US Small Mi.. 0.65 % 0.25 %

+0.26 (+0.22%)

USD 0.28B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.89% 72% C 93% A
Dividend Return 3.89% 16% F 67% D+
Total Return 41.78% 72% C 94% A
Trailing 12 Months  
Capital Gain 53.30% 66% D+ 90% A-
Dividend Return 5.71% 16% F 71% C-
Total Return 59.02% 72% C 91% A-
Trailing 5 Years  
Capital Gain 34.70% 90% A- 63% D
Dividend Return 23.46% 54% F 74% C
Total Return 58.16% 97% N/A 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.02% N/A N/A 64% D
Dividend Return 13.33% N/A N/A 70% C-
Total Return 5.31% N/A N/A 82% B
Risk Return Profile  
Volatility (Standard Deviation) 22.59% N/A N/A 46% F
Risk Adjusted Return 59.02% N/A N/A 75% C
Market Capitalization 0.83B 71% C- 76% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.30 50% 12%
Price/Book Ratio 2.44 50% 35%
Price / Cash Flow Ratio 30.65 21% 9%
Price/Free Cash Flow Ratio 29.88 14% 9%
Management Effectiveness  
Return on Equity 5.38% 71% 42%
Return on Invested Capital 6.85% 79% 55%
Return on Assets 4.47% 88% 70%
Debt to Equity Ratio 42.04% 68% 64%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.